Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Palexia
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Palexia SR 50mg tablets
0407020AGBBACAC
|
Palexia | Tapentadol | Central Nervous System | 672 |
|
Palexia SR 100mg tablets
0407020AGBBADAD
|
Palexia | Tapentadol | Central Nervous System | 467 |
|
Palexia 50mg tablets
0407020AGBBAAAA
|
Palexia | Tapentadol | Central Nervous System | 352 |
|
Palexia SR 200mg tablets
0407020AGBBAFAF
|
Palexia | Tapentadol | Central Nervous System | 264 |
|
Palexia SR 150mg tablets
0407020AGBBAEAE
|
Palexia | Tapentadol | Central Nervous System | 225 |
|
Palexia SR 250mg tablets
0407020AGBBAGAG
|
Palexia | Tapentadol | Central Nervous System | 100 |
|
Palexia 20mg/ml oral solution
0407020AGBBAHAH
|
Palexia | Tapentadol | Central Nervous System | 19 |
|
Palexia 75mg tablets
0407020AGBBABAB
|
Palexia | Tapentadol | Central Nervous System | 10 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.